Factors affecting PARP inhibitor use as maintenance treatment in platinum-sensitive recurrent ovarian cancer

被引：0
|
作者：
Valentine, Mark [1 ]
Perhanidis, Jessica [2 ]
Hawkes, Carol [2 ]
Thaker, Premal [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO 63110 USA
[2] GlaxoSmithKline, Waltham, MA USA
来源：
GYNECOLOGIC ONCOLOGY | 2021年 / 162卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
291
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [31] Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer
    Antonio Lopez-Guerrero, Jose
    Romero, Ignacio
    Poveda, Andres
    CHINESE JOURNAL OF CANCER, 2015, 34 (01) : 41 - 49
  • [32] PARP INHIBITORS MAINTENANCE THERAPY IN PLATINUM-SENSITIVE RELAPSED OVARIAN CANCER: A COMPREHENSIVE CANCER CENTRE'S EXPERIENCE
    Moreira, I.
    Ferreira, M.
    Lopes, A. R.
    Savva-Bordalo, J.
    Abreu, M.
    Sousa, S.
    Pereira, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A239 - A239
  • [33] Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: Focus on trabectedin
    Poveda, Andres
    Ray-Coquard, Isabelle
    Romero, Ignacio
    Antonio Lopez-Guerrero, Jose
    Colombo, Nicoletta
    CANCER TREATMENT REVIEWS, 2014, 40 (03) : 366 - 375
  • [34] Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer
    Jos Antonio LpezGuerrero
    Ignacio Romero
    Andrs Poveda
    ChineseJournalofCancer, 2015, 34 (01) : 41 - 49
  • [35] Real-life data of niraparib maintenance treatment in patients with recurrent platinum-sensitive ovarian cancer.
    Vilming, Bente
    Fallas-Dahl, Jorgen
    Bentzen, Anne-Gry
    Ingebrigtsen, Vibeke Anett
    Nilsen, Elisabeth Berge
    Vistad, Ingvild
    Dorum, Anne
    Solheim, Olesya
    Bjorge, Line
    Aune, Guro
    Lindemann, Kristina
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] SEARCHING FOR THE BEST MAINTENANCE THERAPY IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: BEVACIZUMAB OR PARP-INHIBITORS? A NETWORK META-ANALYSIS
    Bartoletti, M.
    Pelizzari, G.
    Bortot, L.
    Giavarra, M.
    Vitale, M. G.
    Andreotti, V.
    Parnofiello, A.
    Scalone, S.
    Lombardi, D.
    Nicoloso, M.
    Bozza, C.
    Poletto, E.
    Sacco, C.
    Andreetta, C.
    Sorio, R.
    Puglisi, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A437 - A438
  • [37] A comprehensive comparison of PARP inhibitors as maintenance therapy in platinum-sensitive recurrent ovarian cancer: a systematic review and network meta-analysis
    Ji, Shiya
    Chen, Lu
    Yu, Yebo
    Chen, Xupeng
    Wei, Liwen
    Gou, Lili
    Shi, Cheng
    Zhuang, Susu
    JOURNAL OF OVARIAN RESEARCH, 2025, 18 (01)
  • [38] Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
    Ledermann, Jonathan
    Harter, Philipp
    Gourley, Charlie
    Friedlander, Michael
    Vergote, Ignace
    Rustin, Gordon
    Scott, Clare
    Meier, Werner
    Shapira-Frommer, Ronnie
    Safra, Tamar
    Matei, Daniela
    Macpherson, Euan
    Watkins, Claire
    Carmichael, James
    Matulonis, Ursula
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (15): : 1382 - 1392
  • [39] Secondary cytoreductive surgery for recurrent platinum-sensitive ovarian cancer
    Schorge, John O.
    Wingo, Shana N.
    Bhore, Rafia
    Heffernan, Thomas P.
    Lea, Jayanthi S.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 108 (02) : 123 - 127
  • [40] Effectiveness of pegylated liposomal doxorubicin maintenance therapy for platinum-sensitive recurrent epithelial ovarian cancer
    Blake, E. A.
    Mostofizadeh, S.
    Bradley, C. A.
    Pham, H. Q.
    Yessaian, A.
    Roman, L. D.
    Muggia, F. M.
    Garcia, A.
    Matsuo, K.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 49 - 49
12345